Different intrahepatic recurrence rate after resection of hepatocellular carcinoma associated with chronic hepatitis B and C

Hepatology Research

Volumn 12, Issue 2, 1998, Pages 93-110

  Nagasue, Naofumi ^a   Ohmori, Haruki ^a   Yamanoi, Akira ^a   Kumar Dhar, Dipok ^a   Nazmy El Assal, Osama ^a   Yamamoto, Akitaka ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis B; Chronic hepatitis C; Hepatocellular carcinoma; Intrahepatic recurrence; Liver resection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; CISPLATIN; DECARBOXYPROTHROMBIN; EPIRUBICIN; FIBRINOGEN; FLUOROURACIL; INDOCYANINE GREEN; MITOMYCIN C;

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

EID: 0031718892     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00037-0     Document Type: Article

References (55)

1. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V, Dioguardi N Hepatocellular carcinoma in Italian patients with cirrhosis. New Engl J Med. 325:1991;675-680.
2. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi H, Fujimoto I, Inoue A, Yamazaki H, Kawashima T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New Engl J Med. 328:1993;1797-1801.
3. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 18:1993;47-53.
4. Blum HE Does hepatitis C virus cause hepatocellular carcinoma? Hepatology. 19:1994;251-255.
5. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology. 21:1995;650-655.
6. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E, Brechot C, Paterlini P HCV-associated liver cancer without cirrhosis. Lancet. 345:1995;413-415.
7. Tanaka K, Ikematsu H, Kashiwagi S Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: Possible role of type lb (II) infection. J Natl Cancer Inst. 88:1996;742-746.
8. Benvegnu L, Alberti A Risk factors and prevention of hepatocellular carcinoma in HCV infection. Dig Dis Sci. 41:1996;49S-55.
9. Bismuth H, Chiche L, Castaung D Surgical treatment of hepatocellular carcinoma in noncirrhotic liver: Experience with 68 liver resections. World J Surg. 19:1995;35-41.
10. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, Yukaya H Liver resection for hepatocellular carcinoma: Result of 229 consecutive patients during 11 years. Ann Surg. 217:1993;375-384.
11. Couinaud C. Le Foie: Etudes Anatomiques et Chirurgicales. New York: Masson, 1957.
12. Beahrs OH, Myers MH. Manual for Staging of Cancer. Philadelphia: Lippincott, 1983.
13. Gibson JB, Sobin LH. Histological typing of tumors of the liver, biliary tract and pancreas (International Histological Classification of Tumours, no.209). Geneva: World Health Organization, 1978.
14. Edmondson HA, Steiner PK Primary carcinoma of the liver: A study of 100 cases among 48 900 necropsies. Cancer. 7:1954;452-503.
15. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH The morphology of cirrhosis: Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 31:1978;395-414.
16. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, Yamada G, Hino K, Yokosuka O, Suzuki H New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 6:1996;112-119.
17. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
18. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC Jr, Balart LA, Ortego TJ, Payne J, Dienstag JL, Gibas A, Jacobson IM, Tamburro CH, Carey W, O'Brien C, Sampliner R, Van Thiel DH, Feit D, Albrecht J, Meshcievitz C, Sanghvi B, Vaughan RD Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. Gastroenterology. 104:1993;595-603.
19. Anthony PP, Vogel CL, Barker LF Liver cell dysplasia: A premalignant condition. J Clin Pathol. 26:1973;217-223.
20. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
21. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxi A, Ciccaglione A, Giuseppetti R, Stroffolini T, Pagliaro L Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: A case-control study. Ann Intern Med. 116:1992;97-102.
22. El-Refaie A, Savage K, Bhattacharya S, Khakoo S, Harrison TJ, El-Batanony M, Soliman E-S, Nasr S, Mokhtar N, Amer K, Scheuer PJ, Dhillon AP. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol 1996;24: 277-285.
23. Gerber MA, Shieh CYS, Shim KS, Swan NT, Demetris AJ, Schwartz M, Akyol G, Dash S Detection of replicative C virus sequences in hepatocellular carcinoma. Am J Pathol. 141:1992;1271-1277.
24. Horiike N, Nonaka T, Kumamoto I, Kajino K, Onji M, Ohta Y Hepatitis C virus plus- and minus-stranded RNA in hepatocellular carcinoma and adjoining nontumorous liver. J Med Virol. 41:1993;312-315.
25. Haruna Y, Hayashi N, Kamada T, Hytiroglou P, Thung SN, Gerber MA Expression of hepatitis C virus in hepatocellular carcinoma. Cancer. 73:1994;2253-2258.
26. Sakamuro D, Furakawa T, Takegami T Hepatitis C virus nonstructual protein NS3 transforms NIH 3T3 cells. J Virol. 69:1995;3893-3896.
27. Takamisawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Ohnishi E, Andoh T, Yoshida I, Okayama H Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 65:1991;1105-1113.
28. Hino O, Kajino K Hepatitis virus-related hepatocarcinogenesis. Intervirology. 37:1994;133-135.
29. Ray RB, Lagging LM, Meyer K, Steele R, Ray R Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:1995;209-220.
30. Yamanaka N, Tanaka T, Tanaka W, Yamanaka J, Yasui C, Kuroda N, Takada M, Okamoto E Correlation of hepatitis virus serological status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer. 79:1997;1509-1515.
31. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M, Sassa T Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 25:1997;87-92.
32. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K A comparison of the surgical results in patients with hepatitis B versus C-related hepatocellular carcinoma. Hepatology. 22:1995;20-24.
33. Miyazawa S, Kawasaki S, Makuuchi M Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology. 24:1996;307-310.
34. Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, Cecchetto A, Grigioni W Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: The role of etiology, disease activity, iron, and lipid peroxydation. Hepatology. 23:1996;1468-1475.
35. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology. 19:1994;1354-1359.
36. Nardone G, Romano M, Calabro A, Pedone PV, De Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R Activation of fetal promoters of insulin-like growth factor II in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatology. 23:1996;1304-1312.
37. Noguchi O, Enomoto N, Ikeda T, Kobayashi F, Marumo F, Sato C Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma. J Hepatol. 24:1996;286-292.
38. Mazzanti R, Messerini L, Monsacchi L, Buzzelli G, Zignego AL, Foschi M, Monti M, Laffi G, Morbidelli L, Fantappie O, Omer FBS, Ziche M Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. Hepatology. 25:1997;229-234.
39. Purtilo D, Gottlieb LS Cirrhosis and hepatoma occurring at Boston City Hospital 1917-1968). Cancer. 32:1973;458-462.
40. Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loreal O, Campion JP, Launois B, Ramee M-P, Brissot P, Deugnier Y. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 1995;22:446-450.
41. Bacon BR, Britton RS The pathology of hepatic iron overload: A free radical-mediated process? Hepatology. 11:1990;127-137.
42. Farinati F, Cardin R, De Maria N, Libera GD, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R Iron storage, lipid peroxydation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 22:1995;449-456.
43. Roncalli M, Borzio M, De Biagi G, Ferrari AR, Macchi R, Tombesi VM, Servida E Liver cell dysplasia in cirrhosis: A serologic and immunohistochemical study. Cancer. 57:1986;1515-1521.
44. Thomas RM, Berman JJ, Yetter RA, Moore GW, Hutchins GM Liver cell dysplasia: A DNA aneuploid lesion with distinct morphologic features. Hum Pathol. 23:1992;496-503.
45. Henmi A, Uchida T, Shikata T Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma: Evidence against precancerous nature of liver cell dysplasia. Cancer. 55:1985;2594-2599.
46. Cohen C, Berson SD Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients. Cancer. 57:1986;1535-1538.
47. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, Takahashi M. Morphologic studies of the liver cell dysplasia. Cancer. 51:1983;2197-2205.
48. Borzio M, Bruno S, Roncalli M, Mels GC, Ramella G, Borzio F, Leandro G, Servida E, Podda M Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study. Gastroenterology. 108:1995;812-817.
49. Ganne-Carrie N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, Deny P, Trinchet J-C, Callard P, Guettier C, Beaugrand M Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology. 23:1996;1112-1118.
50. Ono T, Nagasue N, Kohno H, Hayashi T, Uchida M, Yukaya H, Yamanoi A Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: A prospective randomized study. Semin Oncol. 24:1997;6-18-S6-25.
51. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 346:1995;1051-1055.
52. Mazella G, Accogli E, Scothlli S, Festi D, Orsini M, Salzetta A, Novelli V, Cipolla A, Fabbri C, Pezzoli A, Roda E α-interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol. 24:1996;141-147.
53. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T For the Hepatoma Prevention Study Group. Prevention of second prunary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. New Engl J Med. 334:1996;1561-1567.
54. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, Monna T, Kobayashi K, Tango T Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saikotou (TJ-9). Cancer. 76:1995;743-749.
55. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer. 79:1997;1494-1500.